UF Health Gene Therapy Scientist Named to Florida Inventors Hall of Fame
Byrne, director of the UF Powell Center for Rare Disease Research and Therapy and a gene therapy pioneer with about 23 patents in the field, will be inducted into the 2024 class of the Florida Inventors Hall of Fame in the fall, the organization announced May 30.
Florida Inventors Hall of Fame Celebrates 2024 Inductees: Ushering in a New Era of Innovation
The Florida Inventors Hall of Fame has announced its 2024 inductees: nine visionaries whose groundbreaking inventions have propelled technological advancement and reshaped the landscape of American innovation. These inventors, which include prolific University of Florida researcher Barry Byrne, who founded the field of muscle gene therapy, exemplify Florida’s rich tradition of ingenuity.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
Does My Child Have Duchenne Muscular Dystrophy? Take the Quiz.
Duchenne muscular dystrophy — sometimes referred to simply as Duchenne — is a genetic disorder that causes progressive muscle loss and weakness. It occurs as a result of gene mutations involved in the production of a protein called dystrophin, according to the Muscular Dystrophy Association (MDA).
Dr. Barry Byrne Presents Improvements in Key Duchenne Muscular Dystrophy Measures, Microdystrophin Expression
Data presented by Barry Byrne, MD, Ph.D. suggest that intravenous SGT-001 (Solid Biosciences) is well-tolerated and efficacious in DMD.
Barry Byrne, MD, Ph.D.: Landscape of Awareness for Neuromuscular Disease
Barry J. Byrne, MD, Ph.D., chief medical advisor of the Muscular Dystrophy Association and associate chair of pediatrics and director at the University of Florida Powell Center for Rare Disease Research and Therapy, talked with NeurologyLive about the virtual telethon to create awareness for a number of neuromuscular diseases.
Dr. Barry Byrne Receives “See the Light” Award From the Mathew Forbes Romer Foundation
For families facing a devastating diagnosis of pediatric neurodegenerative genetic disease, Barry Byrne, M.D., Ph.D., provides a sense of hope and possibility.... Read More
Gene Therapy Company AavantiBio Launches With $107 Million Series A Financing From Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management and Sarepta Therapeutics
A premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, together with Sarepta Therapeutics,... Read More
University of Florida Received £500,000 Grant From Duchenne UK to Overcome Immunity Challenges in Gene Therapy
Duchenne UK has partnered with one of the world’s leading gene therapy teams focusing on AAV immunology. Drs. Manuela Corti and Barry... Read More
Adapting Neurological Care Amid COVID-19
As the ongoing battle against the spread of COVID-19 continues, the medical community is learning more about the disease and at-risk populations... Read More
